- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Carvedilol IR (Immediate Release)
Total 267 results
-
PfizerCompletedHealthy ParticipantsBelgium
-
BayerCompletedRenal Impairment | Chronic Kidney Disease | Healthy VolunteersGermany
-
AlexionRecruiting
-
AstraZenecaWithdrawnHealthy Male Subjects | Pharmacokinetics | Safety | Food EffectUnited Kingdom
-
CTI-1, LLCGlaxoSmithKline; CTI Clinical Trial and Consulting ServicesCompletedCongestive Heart FailureUnited States
-
Seoul National University Bundang HospitalChong Kun Dang Pharmaceutical Corp.UnknownHeart Failure With Reduced Ejection FractionKorea, Republic of
-
Elcelyx Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States
-
GlaxoSmithKlineCompletedHeart Failure, CongestiveJapan
-
Johnson & Johnson Pharmaceutical Research & Development...Grünenthal GmbHCompleted
-
Hangzhou Highlightll Pharmaceutical Co., LtdCompleted
-
Azurity PharmaceuticalsCompletedAbuse PotentialUnited States
-
GlaxoSmithKlineQuotient ClinicalCompletedAutoimmune DiseasesUnited Kingdom
-
GlaxoSmithKlineQuotient SciencesCompletedAutoimmune DiseasesUnited Kingdom
-
Heptares Therapeutics LimitedQuotient ClinicalCompletedAlzheimer's DiseaseUnited Kingdom
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Botswana, Germany, South Africa
-
PfizerCompletedHealthy ParticipantsBelgium
-
PfizerCompleted
-
AstraZenecaCompletedSchizophrenic DisorderBulgaria, Russian Federation, Romania, South Africa, Greece, Philippines, India, Indonesia
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
AstraZenecaCompleted
-
Mundipharma Research LimitedTerminatedPolymyalgia RheumaticaUnited Kingdom
-
Dinora, Inc.PharPoint Research, Inc.; Analgesic SolutionsTerminated
-
AstraZenecaTerminatedPsychotic Disorders | Schizophrenia | Schizoaffective DisordersUnited Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2 | Type 2 Diabetes MellitusUnited States
-
PfizerCompletedHealthy ParticipantsBelgium
-
PfizerCompletedHealthy SubjectsUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaCompleted
-
Janssen Research & Development, LLCCompleted
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of YM178Netherlands
-
Alza Corporation, DE, USACompleted
-
PfizerViiV HealthcareCompleted
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
ApoPharmaCompleted
-
GlaxoSmithKlineTerminated
-
Janssen Research & Development, LLCCompleted
-
Ensysce BiosciencesCompletedRecreational Drug UseUnited States
-
Boehringer IngelheimCompletedTourette SyndromeUnited States, Germany
-
Roy D. Bloom, MDVeloxis PharmaceuticalsRecruitingKidney Transplant; ComplicationsUnited States
-
Sarfez Pharmaceuticals, Inc.RecruitingHeart Failure | Overactive Bladder | IncontinenceUnited States
-
Boehringer IngelheimCompleted
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Desitin Arzneimittel GmbHFGK Clinical Research GmbHTerminated
-
KalVista Pharmaceuticals, Ltd.Completed
-
Sheba Medical CenterCompletedADHD Predominantly Inattentive Type | Attention Deficit/Hyperactivity Disorder Combined Type | ADHD Predominantly Hyperactivity Type | ADHD-not Other SpecifiedIsrael
-
APOGEPHA Arzneimittel GmbHCompletedUrologic Diseases | Urinary Incontinence | Urinary Bladder, Neurogenic | Neurogenic Urinary Bladder Disorder | Bladder Disorder, Neurogenic | Urinary Bladder Disorder, Neurogenic | Neurogenic Bladder Disorder | Urinary Bladder Neurogenic Dysfunction | Overactive Detrusor FunctionRomania, Austria, Germany
-
Alexion PharmaceuticalsCompleted
-
Boehringer IngelheimCompleted